StockRing.com   Home    DOW 30+    ENERGY    HEALTH    FINANCE    SERVICES    TECH   
  iPhone   Ratings   Profile   Charts   Quotes   News   Blogs   VIX   
 7/29/2014, (NASDAQ:SLXP), $131.32 -0.90, -0.68%, "BUY" Salix Pharmaceuti Stock
 




  
  

SLXP rating is generated by our FREE iPhone App Buy-Sell-Hold+ that covers 4,030 stocks & ETFs

On   7/29/2014   StockRing.com recommends to   "BUY"   SLXP   stock at current price of   $131.32.
Today SLXP stock opened at $131.90 and was trading in the daily range of $ 129.465 - 132.40 per share.
Salix Pharmaceuti (NASDAQ:SLXP) Market capitalization is $8.327B. SLXP average daily volume is 1,092,850.
On last trading session SLXP stock traded 768,764 shares. Also the Short Ratio for (NASDAQ:SLXP) stock is 9.20.
Last year Salix Pharmaceuti(NASDAQ:SLXP) before taxes (EBITDA) (ttm) earned $379.1M on revenue of $1.116B.
SLXP 50-Day Moving Average is $126.84 vs. $131.32 now and 200-Day Moving Average is $111.04 vs. $131.32.
--------------------------------------------------------------------------------------------------------------------
VIX is "HOLD".  Nasdaq is "HOLD".  S&P 500 is "HOLD" on  5/16/2014
--------------------------------------------------------------------------------------------------------------------
SLXP Earnings Per Share - EPS (ttm) is 1.18. SLXP Stock Price Per Earnings ratio - P/E is 112.34.
Salix Pharmaceuti(NASDAQ:SLXP) stock pays a dividend of $0.00 per share which is a yield of N/A%.
On average analysts predict that One Year Target Estimated price for SLXP stock is $155.75.
In the last 52 weeks SLXP stock was trading in the range of $64.93 - 141.81.
 
 
  Our FREE iPhone App Buy-Sell-Hold ratings for 4568 stocks & ETFs:
 
1. DOW30+    Part 1    199 Stocks    Updated: 5/16/2014 6:13:26 PM
2. DOW30+    Part 2    192 Stocks    Updated: 5/16/2014 6:18:11 PM
3. DOW30+    Part 3    193 Stocks    Updated: 5/16/2014 6:23:19 PM
4. DOW30+    Part 4    195 Stocks    Updated: 5/16/2014 6:27:30 PM
 
5. ENERGY    Part 1    188 Stocks    Updated: 5/30/2014 10:49:50 AM
6. ENERGY    Part 2    186 Stocks    Updated: 5/30/2014 10:45:38 AM
7. ENERGY    Part 3    196 Stocks    Updated: 5/30/2014 10:40:22 AM
 
8. HEALTH    Part 1    184 Stocks    Updated: 5/19/2014 11:03:20 PM
9. HEALTH    Part 2    138 Stocks    Updated: 5/19/2014 11:06:54 PM
 
10. FINANCE    Part 1    191 Stocks    Updated: 5/29/2014 9:02:46 AM
11. FINANCE    Part 2    190 Stocks    Updated: 5/29/2014 9:08:02 AM
12. FINANCE    Part 3    188 Stocks    Updated: 5/29/2014 9:13:08 AM
13. FINANCE    Part 4    188 Stocks    Updated: 5/29/2014 9:17:57 AM
14. FINANCE    Part 5    190 Stocks    Updated: 5/29/2014 9:22:59 AM
 
15. SERVICE    Part 1    181 Stocks    Updated: 5/22/2014 12:09:15 AM
16. SERVICE    Part 2    185 Stocks    Updated: 5/22/2014 12:10:17 AM
17. SERVICE    Part 3    183 Stocks    Updated: 5/22/2014 12:02:57 AM
18. SERVICE    Part 4    193 Stocks    Updated: 5/22/2014 12:07:53 AM
 
19. TECH    Part 1    187 Stocks    Updated: 5/20/2014 10:04:33 AM
20. TECH    Part 2    183 Stocks    Updated: 5/20/2014 10:10:24 AM
21. TECH    Part 3    184 Stocks    Updated: 5/20/2014 10:15:47 AM
22. TECH    Part 4    102 Stocks    Updated: 5/20/2014 10:27:15 AM
 
23. IPOs    200 Stocks    Updated:  TODAY , 6/10/2014 3:37:13 AM
 
24. ETFs    Part 1    193 Stocks    Updated: 5/16/2014 6:48:58 PM
25. ETFs    Part 2    191 Stocks    Updated: 5/16/2014 6:52:54 PM
26. ETFs    Part 3    157 Stocks    Updated: 5/16/2014 6:56:31 PM

BUY  DOW 30+:    ENERGY: ADMA  RNG  CDW  CBA  BLUE     HEALTH: ACWX  EPHE  FM  DVYA  AOM 
      FINANCE: XLK  DWX  BWZ  GII  SCPB     SERVICES: UST  MLPX  BRAQ  YCL  EMFM     TECH: CSGP  WDC  ONNN  RENN  JNPR 
SELL  DOW 30+: GGB     ENERGY: RMAX  SEAS  NBCB  PETX  VOYA     HEALTH: ITA  ICLN  EIRL  SCZ  PICK 
      FINANCE: XME  XSW  KBE  EWO  BAL     SERVICES: VIXM  EEV  UVXY  QID  AGQ     TECH: BRKR  CPHD  IPGP  LLTC  MDRX 


Samples of StockRing Real Time "Buy-Sell-Hold" stock Ratings:



  Enter Stock:  
  
    
    
 
 



Download StockRing Free  Buy-Sell-Hold iPhone
App for 1,200 stocks in Energy Healthcare Finance Services & Tech


DOW 30+

ENERGY

HEALTH

FINANCE

SERVICES

TECH

  Our FREE iPhone App Buy-Sell-Hold ratings for 4568 stocks & ETFs:
 
1. DOW30+    Part 1    199 Stocks    Updated: 5/16/2014 6:13:26 PM
2. DOW30+    Part 2    192 Stocks    Updated: 5/16/2014 6:18:11 PM
3. DOW30+    Part 3    193 Stocks    Updated: 5/16/2014 6:23:19 PM
4. DOW30+    Part 4    195 Stocks    Updated: 5/16/2014 6:27:30 PM
 
5. ENERGY    Part 1    188 Stocks    Updated: 5/30/2014 10:49:50 AM
6. ENERGY    Part 2    186 Stocks    Updated: 5/30/2014 10:45:38 AM
7. ENERGY    Part 3    196 Stocks    Updated: 5/30/2014 10:40:22 AM
 
8. HEALTH    Part 1    184 Stocks    Updated: 5/19/2014 11:03:20 PM
9. HEALTH    Part 2    138 Stocks    Updated: 5/19/2014 11:06:54 PM
 
10. FINANCE    Part 1    191 Stocks    Updated: 5/29/2014 9:02:46 AM
11. FINANCE    Part 2    190 Stocks    Updated: 5/29/2014 9:08:02 AM
12. FINANCE    Part 3    188 Stocks    Updated: 5/29/2014 9:13:08 AM
13. FINANCE    Part 4    188 Stocks    Updated: 5/29/2014 9:17:57 AM
14. FINANCE    Part 5    190 Stocks    Updated: 5/29/2014 9:22:59 AM
 
15. SERVICE    Part 1    181 Stocks    Updated: 5/22/2014 12:09:15 AM
16. SERVICE    Part 2    185 Stocks    Updated: 5/22/2014 12:10:17 AM
17. SERVICE    Part 3    183 Stocks    Updated: 5/22/2014 12:02:57 AM
18. SERVICE    Part 4    193 Stocks    Updated: 5/22/2014 12:07:53 AM
 
19. TECH    Part 1    187 Stocks    Updated: 5/20/2014 10:04:33 AM
20. TECH    Part 2    183 Stocks    Updated: 5/20/2014 10:10:24 AM
21. TECH    Part 3    184 Stocks    Updated: 5/20/2014 10:15:47 AM
22. TECH    Part 4    102 Stocks    Updated: 5/20/2014 10:27:15 AM
 
23. IPOs    200 Stocks    Updated:  TODAY , 6/10/2014 3:37:13 AM
 
24. ETFs    Part 1    193 Stocks    Updated: 5/16/2014 6:48:58 PM
25. ETFs    Part 2    191 Stocks    Updated: 5/16/2014 6:52:54 PM
26. ETFs    Part 3    157 Stocks    Updated: 5/16/2014 6:56:31 PM

 DOW 30+    ENERGY    HEALTH    FINANCE    SERVICES    TECH
  Up   iPhone   Ratings   Profile   Charts   Quotes   News   Blogs   VIX   

Our FREE iPhone App with Buy-Sell-Hold ratings for 4,030 stocks:

  iPhone App Buy-Sell-Hold Ratings for 5-5-2013
           
           
           
           
     
  

 
  Enter Stock:  
  
    
    
 



7/29/2014  Tuesday, July 29, 2014 (Irvine, California) Today StockRing.com Recommendation is to "BUY"for Salix Pharmaceuti (NASDAQ:SLXP) Stock. SLXP stock opening price was $131.90 per share. Current price of NASDAQ:SLXP Stock is $131.32 per share and it is $-0.90, (-0.68%) today and it was trading in the daily range of $129.465 - 132.40 per share. Current Bid Price for (NASDAQ:SLXP) stock is $131.40 and the Ask Price is $132.90. In the last 52 weeks SLXP stock was trading in the range of $64.93 - 141.81. 50-Day Moving Average for (NASDAQ:SLXP) stock is $126.84 and 200-Day Moving Average is $111.04. On average analysts predict that One Year Target Estimated price for (NASDAQ:SLXP) stock is $155.75.

Salix Pharmaceuti (NASDAQ:SLXP) is rated as a buy on 5/19/2014 11:06:54 PM.

Salix Pharmaceuti (NASDAQ:SLXP) Market capitalization is $8.327B. (NASDAQ:SLXP) stock average daily volume is 1,092,850 shares per day. However, on last trading session of Jul 28, 2012 SLXP stock traded 768,764 shares. Also The Number of days it would take short sellers on average to repurchase all the borrowed shares or Short Ratio for (NASDAQ:SLXP) stock is 9.20. On previous trading session SLXP Stock closed at $132.22 per share.

Last year Salix Pharmaceuti (NASDAQ:SLXP) before taxes (EBITDA) (ttm) earned $379.1M on total revenue of $1.116B. Earnings Per Share - EPS (ttm) for SLXP stock is 1.18. Also, (NASDAQ:SLXP) Stock Price Per Earnings ratio - P/E is 112.34. Thus, (NASDAQ:SLXP) Stock Price/Sales (ttm) ratio is 7.51 and Price/Book (mrq) ratio is 11.78.

(NASDAQ:SLXP) Stock does NOT PAY any dividend. So at this time (NASDAQ:SLXP) Stock maintains Trailing Annual Dividend Rate at 0.00 .


StockRing Recommendations for Salix Pharmaceuti (NASDAQ:SLXP) Stock are updated daily here

http://StockRing.com/sr/Buy-Sell-Hold-Stock-Analysis-Ratings.asp?StockName=SLXP

At this time StockRing recommends to buy LONG positions on many stocks from Dow 30+ stocks that currently have a BUY or SUPER BUY rating. If you decide to take a SHORT position and actually sell some stocks sjort right now - please check the section of Dow 30+ stocks that have a SELL or SUPER SELL rating.

If you would like to receive Buy-Sell-Hold ratings for stocks from Energy, Healthcare, Finance, Services & Hi-Tech sectors on your iPhone, then please download Buy-Sell-Hold iPhone App here:


Free Limited or $10 Full Version  Buy-Sell-Hold iPhone App
for 1,200 stocks in Energy, Healthcare, Finance, Services and Tech


DOW 30+

ENERGY

HEALTH

FINANCE

SERVICES

TECH


 
  Enter Stock:  
  
    
    
 
 DOW 30+    ENERGY    HEALTH    FINANCE    SERVICES    TECH
  Up   iPhone   Ratings   Profile   Charts   Quotes   News   Blogs   VIX   

NASDAQ:SLXP Stock Charts:   1d   5d   3m   6m   1y   2y   5y   Max    Options   More Info

SLXP rating is generated by our FREE iPhone App Buy-Sell-Hold+ that covers 4,030 stocks & ETFs

7/29/2014 1 Year Stock market price chart for Salix Pharmaceuti (NASDAQ:SLXP) Stock on Tuesday, July 29, 2014
  
1 Year SLXP 1 Year Dow Jones
1 Year Nasdaq 1 Year S&P 500
7/29/2014 5 days Stock market price chart for Salix Pharmaceuti (NASDAQ:SLXP) Stock on Tuesday, July 29, 2014
  
5 Days SLXP 5 Days Dow Jones
5 Days Nasdaq 5 Days S&P 500
  

EUROs for $1 DOLLAR: 30 days
     

NASDAQ:SLXP Stock Charts:   1d   5d   3m   6m   1y   2y   5y   Max    Options   More Info
 DOW 30+    ENERGY    HEALTH    FINANCE    SERVICES    TECH
  Up   iPhone   Ratings   Profile   Charts   Quotes   News   Blogs   VIX   

SLXP rating is generated by our FREE iPhone App Buy-Sell-Hold+ that covers 4,030 stocks & ETFs

7/29/2014 Stock market price quote data for Salix Pharmaceuti (NASDAQ:SLXP) Stock on Tuesday, July 29, 2014

Last Trade: 131.32
Trade Time: Jul 28
Change: -0.90, (-0.68%)
Prev Close: 132.22
Open: 131.90
Bid: 131.40
Ask: 132.90
1y Target Est: $155.75
50-Day Moving Average: 126.84
200-Day Moving Average:
111.04
Short Ratio: 9.20
Trailing Annual Dividend Rate: 0.00
Day's Range: 129.465 - 132.40
52wk Range: 64.93 - 141.81
Volume: 768,764
Avg Vol: 1,092,850
Market Cap: 8.327B
P/E (ttm): 112.34
EPS (ttm): 1.18
Div & Yield: 0.00 (N/A%)
Revenue (ttm): 1.116B
Earnings before Tax (EBITDA) (ttm): 379.1M
Price/Sales (ttm): 7.51
Price/Book (mrq): 11.78
 DOW 30+    ENERGY    HEALTH    FINANCE    SERVICES    TECH
  Up   iPhone   Ratings   Profile   Charts   Quotes   News   Blogs   VIX   

  
  
 DOW 30+    ENERGY    HEALTH    FINANCE    SERVICES    TECH
  Up   iPhone   Ratings   Profile   Charts   Quotes   News   Blogs   VIX   

SLXP rating is generated by our FREE iPhone App Buy-Sell-Hold+ that covers 4,030 stocks & ETFs



7/29/2014 Latest stock market news data for Salix Pharmaceuti (NASDAQ:SLXP) Stock on Tuesday, July 29, 2014

 DOW 30+    ENERGY    HEALTH    FINANCE    SERVICES    TECH
  Up   iPhone   Ratings   Profile   Charts   Quotes   News   Blogs   VIX   

SLXP rating is generated by our FREE iPhone App Buy-Sell-Hold+ that covers 4,030 stocks & ETFs

Why Salix Pharmaceuticals Ltd. Stock Surged
Motley Fool - Jul 1, 2014
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.
Salix Pharmaceuticals, Ltd. Is An Excellent Take-Over Target: Canaccord - ValueWalk
Salix Pharmaceuticals (SLXP) Strong In Pre-Market Trading - TheStreet.com
Salix Pharmaceuticals Announces 2Q2014 Financial Results Conference Call ...
MarketWatch - Jul 24, 2014
RALEIGH, N.C., Jul 24, 2014 (BUSINESS WIRE) -- Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced that the Company will report second quarter 2014 financial results following the close of the U.S.
INVESTOR ALERT -- Salix Pharmaceuticals, Ltd.: The Law Offices of Vincent ...
Wall Street Journal - Jul 21, 2014
The Law Offices of Vincent Wong are investigating potential claims against the Board of Directors of Salix Pharmaceuticals, Ltd. (Nasdaq: SLXP) ("Salix Pharmaceuticals") in connection with the sale of the Company to a subsidiary of Cosmo ...
Salix Pharmaceuticals, Ltd. (SLXP) Insiders Sell Stock In The Company
Tech Insider - Jul 4, 2014
Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP), saw four insiders lower their exposure to the company. William P. Forbes, the EVP of Research & Development & the company's CDO, sold 1,971 shares of common stock at an average of $123.35 per share; EVP ...
Salix Pharmaceuticals Ltd. (SLXP) Is Losing Ground After Merger Agreement
RTT News - Jul 9, 2014
Salix Pharmaceuticals Ltd. (SLXP: Quote) announced after the bell Tuesday that it entered into a definitive merger agreement with Cosmo Technologies Limited.
Salix Stock Plunges Following Merger News - Bidness Etc
Salix Pharmaceuticals: The Newest Inversion Play - Wall Street Journal (blog)
Deals of the day: Salix Pharma does tax inversion dance
Fortune - Jul 10, 2014
Salix Pharmaceuticals Ltd. (Nasdaq: SLXP), a North Carolina-based drug company focused on gastrointestinal diseases, has agreed to merge with Cosmo Pharmaceuticals (SIX: COPN), an Italian rug-maker domiciled in Ireland.
Unusual Social Activity Today Around Salix Pharmaceuticals (SLXP)
TheStreet.com - Jul 1, 2014
SALIX PHARMACEUTICALS LTD has experienced a steep decline in earnings per share in the most recent quarter in comparison to its performance from the same quarter a year ago.
Salix Pharmaceuticals Ltd.: Salix Pharmaceuticals to Combine with Cosmo ...
The Wall Street Transcript - Jul 11, 2014
RALEIGH, N.C. & LAINATE, Italy--(BUSINESS WIRE)--Salix Pharmaceuticals, Ltd. ("Salix") (NASDAQ: SLXP) and Cosmo Pharmaceuticals S.p.
Salix successful in appeal of Relistor label expansion CRL
Seeking Alpha - Jul 14, 2014
The FDA's Office of Drug Evaluation III notifies Salix Pharmaceuticals (NASDAQ:SLXP) that the data submitted in its sNDA for a label expansion for Relistor (methylnaltrexone bromide) is sufficient for approval.
Salix Pharmaceuticals Price Target Increased to $150.00 by Analysts at Brean ... - WKRB News
Salix Pharmaceuticals Receives “Outperform” Rating from Leerink Swann (SLXP) - Ticker Report
Salix Pharmaceuticals Surges on Positive IBS Data
Zacks.com - Jul 2, 2014
Salix Pharmaceuticals, Ltd.'s (SLXP - Analyst Report) shares jumped 13.51% after the company announced encouraging data from a phase III study on Xifaxan (rifaximin) 550 mg.

 
DOW 30+    ENERGY    HEALTH    FINANCE    SERVICES    TECH
  Up   iPhone   Ratings   Profile   Charts   Quotes   News   Blogs   VIX   

 DOW 30+    ENERGY    HEALTH    FINANCE    SERVICES    TECH
  Up   iPhone   Ratings   Profile   Charts   Quotes   News   Blogs   VIX   

SLXP rating is generated by our FREE iPhone App Buy-Sell-Hold+ that covers 4,030 stocks & ETFs


7/29/2014 News from StockRing Blog about Salix Pharmaceuti (NASDAQ:SLXP) Stock on Tuesday, July 29, 2014



Copyright © 2014 StockRing.com. All rights reserved.
Subscriber Agreement   Privacy Agreement   Stocks   MutualFunds   Form

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither StockRing.com nor its partners shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the StockRing site, a user agrees not to redistribute the information found therein.